EPA:ABVX.PA 10 December 2025

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Shares in French biotech Abivax SA closed down 9.49% at 99.20 euros on Thursday, after swinging between 112.40 euros at the open and a low of 94.20 euros. The stock slipped back under the 100-euro mark, with volume at about 246,000 shares, after a 6% rise the day before. MarketScreener

8 January 2026

EPA:ABVX.PA·Stock Market

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in which the French biotech has transformed from a relatively obscure name into a multibillion‑euro inflammatory bowel disease contender.Reuters+1

10 December 2025

EPA:ABVX.PA·Mergers & Acquisitions·NASDAQ:ABVX·NYSE:LLY·Stock Market